Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
주식 순위 #12782
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
주가
$5.87
마지막 동기화: 2022-11-08
시가총액
$550.43M
변동 (1일)
1.03%
변동 (1년)
0.00%
국가
US
거래 Silverback Therapeutics, Inc. (SBTX)

카테고리

Silverback Therapeutics, Inc. (SBTX)의 주가 이력
최고 종가: $6.02 (2022-11-01 기준)

최저 종가: $33.40 (2020-12-01 기준)
Silverback Therapeutics, Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2022 -10.00%
2021 -79.97%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$750.94 6.02%
CH